Artificial Intelligence in Cancer (AIC, Artif Intell Cancer) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group (BPG). AIC accepts both solicited and unsolicited manuscripts. Articles published in AIC are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of AIC is to showcase and promote distinguished research in the field of artificial intelligence in cancer, to help advance development of this field. The types of articles published in the AIC include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Cedric Coulouarn, PhD, Academic Research, Senior Researcher, (E-mail: firstname.lastname@example.org) Institut National de la Sante et de la Recherche Medicale (Inserm), Univ Rennes, Rennes 35033, France
- AC Matin, PhD, Professor, (E-mail: email@example.com) Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5124, United States
- Mujib Ullah, MD, PhD, Senior Scientist, (E-mail: firstname.lastname@example.org) Interventional Regenerative Medicine and Imaging Laboratory, Department of Radiology, Stanford University, Palo Alto, CA 94304, United States
There is currently no indexing.
There is currently no impact factor.